Vita Life Sciences Limited (VLS.AX)
AUD 1.78
(0.0%)
AUD 1.78
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -24.24 Million AUD | -60.69% |
| 2022 | -15.08 Million AUD | 2.79% |
| 2021 | -15.52 Million AUD | -25.11% |
| 2020 | -12.4 Million AUD | -52.6% |
| 2019 | -8.12 Million AUD | 8.32% |
| 2018 | -8.86 Million AUD | -14.44% |
| 2017 | -7.74 Million AUD | -11.47% |
| 2016 | -6.95 Million AUD | -0.39% |
| 2015 | -6.92 Million AUD | -19.3% |
| 2014 | -5.8 Million AUD | 35.32% |
| 2013 | -8.97 Million AUD | -78.85% |
| 2012 | -5.01 Million AUD | -38.12% |
| 2011 | -3.63 Million AUD | -367.46% |
| 2010 | 1.35 Million AUD | 425.86% |
| 2009 | 258.25 Thousand AUD | 4031.42% |
| 2008 | -6569.00 AUD | -103.25% |
| 2007 | 201.81 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -27.31 Million AUD | 0.0% |
| 2023 Q4 | -24.24 Million AUD | 0.0% |
| 2023 FY | -24.24 Million AUD | -60.69% |
| 2023 Q2 | -18.28 Million AUD | 0.0% |
| 2022 Q4 | -15.08 Million AUD | 0.0% |
| 2022 FY | -15.08 Million AUD | 2.79% |
| 2022 Q2 | -14.13 Million AUD | 0.0% |
| 2021 FY | -15.52 Million AUD | -25.11% |
| 2021 Q2 | -15.21 Million AUD | 0.0% |
| 2021 Q4 | -15.52 Million AUD | 0.0% |
| 2020 FY | -12.4 Million AUD | -52.6% |
| 2020 Q2 | -10.94 Million AUD | 0.0% |
| 2020 Q4 | -12.4 Million AUD | 0.0% |
| 2019 Q2 | -6.95 Million AUD | 0.0% |
| 2019 FY | -8.12 Million AUD | 8.32% |
| 2019 Q4 | -8.12 Million AUD | 0.0% |
| 2018 Q2 | -7.47 Million AUD | 0.0% |
| 2018 FY | -8.86 Million AUD | -14.44% |
| 2018 Q4 | -8.86 Million AUD | 0.0% |
| 2017 Q2 | -5.98 Million AUD | 0.0% |
| 2017 Q4 | -7.74 Million AUD | 0.0% |
| 2017 FY | -7.74 Million AUD | -11.47% |
| 2016 Q2 | -5.2 Million AUD | 0.0% |
| 2016 FY | -6.95 Million AUD | -0.39% |
| 2016 Q4 | -6.95 Million AUD | 0.0% |
| 2015 Q2 | -7.59 Million AUD | 0.0% |
| 2015 Q4 | -6.92 Million AUD | 0.0% |
| 2015 FY | -6.92 Million AUD | -19.3% |
| 2014 FY | -5.8 Million AUD | 35.32% |
| 2014 Q4 | -5.8 Million AUD | 0.0% |
| 2014 Q2 | -9.68 Million AUD | 0.0% |
| 2013 Q2 | -7.59 Million AUD | 0.0% |
| 2013 FY | -8.97 Million AUD | -78.85% |
| 2013 Q4 | -8.97 Million AUD | 0.0% |
| 2012 FY | -5.01 Million AUD | -38.12% |
| 2012 Q4 | -5.01 Million AUD | 0.0% |
| 2011 FY | -3.63 Million AUD | -367.46% |
| 2011 Q4 | -3.63 Million AUD | 0.0% |
| 2010 Q4 | 1.35 Million AUD | 0.0% |
| 2010 FY | 1.35 Million AUD | 425.86% |
| 2009 Q4 | 258.25 Thousand AUD | 0.0% |
| 2009 FY | 258.25 Thousand AUD | 4031.42% |
| 2008 FY | -6569.00 AUD | -103.25% |
| 2008 Q4 | -6569.00 AUD | 0.0% |
| 2007 FY | 201.81 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | 641 Thousand AUD | 3882.059% |
| Cann Group Limited | 70.82 Million AUD | 134.229% |
| ECS Botanics Holdings Ltd | -2.13 Million AUD | -1036.235% |
| Ecofibre Limited | 18.75 Million AUD | 229.255% |
| Elixinol Wellness Limited | 554 Thousand AUD | 4475.993% |
| Hygrovest Limited | -189 Thousand AUD | -12726.984% |
| IDT Australia Limited | 3.96 Million AUD | 711.579% |
| Invion Limited | -783.52 Thousand AUD | -2994.09% |
| Little Green Pharma Ltd | -532.33 Thousand AUD | -4454.087% |
| Live Verdure Ltd | -1.08 Million AUD | -2143.185% |
| Medical Developments International Limited | -7.44 Million AUD | -225.453% |
| Vitura Health Limited | -6.02 Million AUD | -302.11% |